TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media
Download Report PDF Instantly
Report overview
Vaccines play a crucial role in protecting animals from a large spectrum of diseases caused due to virus, bacteria, protozoa, and other multicellular pathogens.
This report contains market size and forecasts of Veterinary Vaccines in Global, including the following market information:
The global Veterinary Vaccines market was valued at 7184.8 million in 2021 and is projected to reach US$ 11310 million by 2028, at a CAGR of 6.7% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Inactivated Vaccines Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Veterinary Vaccines include Elanco, Merck, Merial, Zoetis, Advaxis, AmpliPhi Biosciences, Aratana Therapeutics, ARKO Labs and Bayer, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Veterinary Vaccines companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Veterinary Vaccines Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Veterinary Vaccines Market Segment Percentages, by Type, 2021 (%)
Global Veterinary Vaccines Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Veterinary Vaccines Market Segment Percentages, by Application, 2021 (%)
Global Veterinary Vaccines Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Veterinary Vaccines Market Segment Percentages, By Region and Country, 2021 (%)
Competitor Analysis
The report also provides analysis of leading market participants including:
Further, the report presents profiles of competitors in the market, key players include:
